Robert Biesen

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 38

Top Topics

Rheumatoid Arthritis

Disease Activity

Positron Emission Tomography

Peripheral Blood

Top Venues

Annals of the rheumatic diseases

Diagnostics (Basel, Switzerland)

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Felix Radny, Katharina Ziegeler, Iris Eshed, Juliane Greese, Dominik Deppe, Carsten Stelbrink, Robert Biesen, Hildrun Haibel, Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Fabian Proft, Kay-Geert A Hermann, Denis Poddubnyy, Torsten Diekhoff, Sevtap Tugce Ulas
Learning imaging in axial spondyloarthritis: more than just a matter of experience. RMD open 10 (1) (2024)
Felix Radny, Katharina Ziegeler, Iris Eshed, Juliane Greese, Dominik Deppe, Carsten Stelbrink, Robert Biesen, Hildrun Haibel, Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Fabian Proft, Kay-Geert A Hermann, Denis Poddubnyy, Torsten Diekhoff, Sevtap Tugce Ulas
Learning imaging in axial spondyloarthritis: more than just a matter of experience. RMD open 10 (1) (2024)
Elise Siegert, Werner Stenzel, David Sinan Koca, Gerhard Krönke, Robert Biesen
More than meets the eye. Annals of the rheumatic diseases (2024)
Felix Radny, Katharina Ziegeler, Iris Eshed, Juliane Greese, Dominik Deppe, Carsten Stelbrink, Robert Biesen, Hildrun Haibel, Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Fabian Proft, Kay-Geert A Hermann, Denis Poddubnyy, Torsten Diekhoff, Sevtap Tugce Ulas
Learning imaging in axial spondyloarthritis: more than just a matter of experience. RMD open 10 (1) (2024)
Felix Radny, Katharina Ziegeler, Iris Eshed, Juliane Greese, Dominik Deppe, Carsten Stelbrink, Robert Biesen, Hildrun Haibel, Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Fabian Proft, Kay-Geert A Hermann, Denis Poddubnyy, Torsten Diekhoff, Sevtap Tugce Ulas
Learning imaging in axial spondyloarthritis: more than just a matter of experience. RMD open 10 (1) (2024)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Rönnblom, Marjan A Versnel, Edward M Vital
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice. Annals of the rheumatic diseases (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Jeffrey Siefert, Jonas Kaufmann, Felix Thiele, Thula Cannon Walter-Rittel, Julian Manuel Michael Rogasch, Robert Biesen, Gerd R Burmester, Holger Amthauer, Udo Schneider, Christian Furth
Performance of Deauville Criteria in [18F] FDG-PET/CT Diagnostics of Giant Cell Arteritis. Diagnostics (Basel, Switzerland) 13 (1) (2023)
Jeffrey Siefert, Jonas Kaufmann, Felix Thiele, Thula Cannon Walter-Rittel, Julian Manuel Michael Rogasch, Robert Biesen, Gerd R Burmester, Holger Amthauer, Udo Schneider, Christian Furth
Performance of Deauville Criteria in [18F] FDG-PET/CT Diagnostics of Giant Cell Arteritis. Diagnostics (Basel, Switzerland) 13 (1) (2023)
Alexander Tobias, Lennard Ostendorf, Robert Biesen, Udo Schneider, Gerd-Rüdiger R Burmester, Falk Hiepe
Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus. Annals of the rheumatic diseases (2023)
Jeffrey Siefert, Jonas Kaufmann, Felix Thiele, Thula Cannon Walter-Rittel, Julian Manuel Michael Rogasch, Robert Biesen, Gerd R Burmester, Holger Amthauer, Udo Schneider, Christian Furth
Performance of Deauville Criteria in [18F] FDG-PET/CT Diagnostics of Giant Cell Arteritis. Diagnostics (Basel, Switzerland) 13 (1) (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Robert Biesen, Tobias Alexander, Gerd-Rüdiger Burmester, Fredrik N Albach
Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple's disease. Rheumatology advances in practice 7 (2) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Javier Rodriguez-Carrio, Agata Burska, Philip Gerard Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital, Marjan Versnel
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Agata Burska, Javier Rodriguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Philip Gerard Conaghan, Marjan Versnel, Ed Vital
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD open 9 (1) (2023)
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik Nils Albach, Jens Klotsche, Veronika Scholz, Lara Maria Jeworowski, Tatjana Schwarz, Alexander Ten Hagen, Jan Zernicke, Victor Max Corman, Christian Drosten, Gerd-Rüdiger R Burmester, Robert Biesen
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases. Annals of the rheumatic diseases 81 (6) (2022)
Robert Biesen, Markus Lerchbaumer, Jan-Paul Frese, Désirée Schaumburg, Maximilian Dölling, Malte C Kleinschmidt, Gerd-Rüdiger Burmester, Christian Furth, Werner Stenzel, Udo Schneider
Granulomatous large vessel phlebitis in sarcoidosis. Rheumatology (Oxford, England) 60 (12) (2022)
Jakob Hoeppner, Vincent Casteleyn, Robert Biesen, Thomas Rose, Wolfram Windisch, Gerd Rüdiger Burmester, Elise Siegert
SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Edgar Wiebe, Dörte Huscher, Désireé Schaumburg, Andriko Palmowski, Sandra Hermann, Thomas Buttgereit, Robert Biesen, Gerd-Rüdiger R Burmester, Yannick Palmowski, Maarten Boers, John H Stone, Christian Dejaco, Frank Buttgereit
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Annals of the rheumatic diseases (2022)
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach, Alexander Ten Hagen, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Florian Kurth, Leif-Erik Sander, Gerd-Rüdiger R Burmester, Florian Klein, Robert Biesen
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination. RMD open 8 (2) (2022)
Fredrik Nils Albach, Gerd-Rüdiger R Burmester, Robert Biesen
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response. Annals of the rheumatic diseases 80 (10) (2021)
Heide Boeth, Robert Biesen, Jeremias Hollnagel, Sandra Herrmann, Rainald M Ehrig, Lorenzo Pelli, William R Taylor, Georg N Duda, Frank Buttgereit
Quantification of morning stiffness to assess disease activity and treatment effects in rheumatoid arthritis. Rheumatology (Oxford, England) 60 (11) (2021)
Torsten Diekhoff, Iris Eshed, Felix Radny, Katharina Ziegeler, Fabian Proft, Juliane Greese, Dominik Deppe, Robert Biesen, Kay Geert Hermann, Denis Poddubnyy
Choose wisely: imaging for diagnosis of axial spondyloarthritis. Annals of the rheumatic diseases (2021)
Marie Burns, Lennard Ostendorf, Robert Biesen, Andreas Grützkau, Falk Hiepe, Henrik E Mei, Alexander Tobias
Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE. International journal of molecular sciences 22 (5) (2021)
Sae Lim von Stuckrad, Jens Klotsche, Robert Biesen, Mareike Lieber, Julia Thumfart, Christian Meisel, Nadine Unterwalder, Tilmann Kallinich
SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus. Lupus 29 (14) (2020)
Lennard Ostendorf, Marie Burns, Pawel Durek, Gitta Anne Heinz, Frederik Heinrich, Panagiotis Garantziotis, Philipp Enghard, Ulrich Richter, Robert Biesen, Udo Schneider, Fabian Knebel, Gerd Burmester, Andreas Radbruch, Henrik E Mei, Mir-Farzin Mashreghi, Falk Hiepe, Tobias Alexander
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. The New England journal of medicine 383 (12) (2020)